Interview: Dr. Mowfak Sakr – Chairman, Organopharma, Egypt
OrganoPharma’s founder and chairman Dr. Mowfak Sakr explains how he founded his company to try and provide the 40 million people in Egypt who lack healthcare insurance of any kind…
ORGANOPHARMA, founded by Dr. Mowfak Sakr, was legally established in 2004, and entered the market in 2007 after the company’s manufacturing facility in Obour City received Egyptian GMP certification.
For Dr. Mowfak Sakr, caring about human health is the aim, quality service is the way. Organopharma is represented in the Egyptian market by several well known products, and the company actively aims to serve the 40 million Egyptians living at or below the poverty line with good quality, safe, and highly affordable products.
Contact
FACTORY: EL OBOUR INDUSTERIAL ZONE, BLOCKS 20005
Tel.: 202 – 287 33 12
Fax: 202 – 287 33 12
email: organomix@Hotmail.com
Web: organo-pharma.com
OrganoPharma’s founder and chairman Dr. Mowfak Sakr explains how he founded his company to try and provide the 40 million people in Egypt who lack healthcare insurance of any kind…
Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export…
Patrick Tete, managing director of Servier Egypt, highlights the cornerstones of his plan to transform the French company’s Egyptian affiliate, discussing its strengths and its place in Servier’s global operations.…
Dr Mohsen Shalaby, President of Nerhadou, explains how he has built Egypt’s leading mineral supplement and nutraceuticals company from scratch within 25 years. He highlights Nerhadou’s innovative solutions and the…
After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system…
Janet Heckman, managing director for the southern and eastern Mediterranean region at the European Bank for Reconstruction and Development (EBRD), discusses the main areas of investment for the Bank and…
Marwa Taher, executive director of the Swiss Egyptian Business Association (SEBA), explains how the association is promoting trade relations between the two countries. She also highlights initiatives of both SEBA…
Amir Ghattas, senior director of the MENA cluster at LEO Pharma, highlights how the company is raising awareness for dermatological diseases in Egypt, having adopted a highly patient-centric focus. He…
Rates of tuberculosis (TB) have dropped dramatically in Egypt over the last 30 years, but there is still work to be done, with the country’s Ministry of Health recently announcing…
Emad Graiss, managing director of Merck North East Africa, explains what it takes to successfully steer a company through a period of economic difficulties, while still growing at a fast…
Mohamed Swilam, country manager of Roche Egypt, explains how ensuring access to medicine in Egypt is not only related to pricing challenges, but also to support healthcare systems, improve diagnosis,…
Ahmed Mostafa, country manager of Amgen in Egypt and Iran, explains how the affiliate has been growing by providing end-to-end solutions. He also gives his take on the Egyptian government’s…
Dr Osama Rostom, deputy head of the Pharmaceutical Chamber of the Federation of Egyptian Industries (FEI), explains how the Egyptian healthcare ecosystem has improved during the last three years thanks…
See our Cookie Privacy Policy Here
